Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-06-07
2011-06-07
Wax, Robert A (Department: 1619)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S400000, C424S490000, C514S215000
Reexamination Certificate
active
07955622
ABSTRACT:
Controlled-release galantamine formulations, including controlled-release particles, pellets, granules, and spheres are described. Controlled-release particles, pellets, granules, and spheres with immediate release top-coat are also described. Method of preparing such formulations and method of treating a variety of disorders are also disclosed.
REFERENCES:
patent: 2005/0191349 (2005-09-01), Boehm et al.
patent: 2007/0092568 (2007-04-01), Gore et al.
patent: 2009/0087488 (2009-04-01), Verma et al.
patent: 00/38686 (1999-12-01), None
patent: 00/38686 (2000-07-01), None
patent: 0038686 (2000-07-01), None
patent: 2005065661 (2005-07-01), None
patent: 20070029081 (2007-03-01), None
Particle Size Conversion Table.
Particle Size Conversion table.
International Searching Authority, International Search Report PCT/US2007/021736, Filing date: Oct. 11, 2007, Mailing date: Apr. 22, 2008, 7 pages.
International Searching Authority, Written Opinion PCT/US2007/021736, Filing date: Oct. 11, 2007, Mailing date: Apr. 22, 2008, 9 pages.
Actavis Group PTC HF
Cantor & Colburn LLP
Wax Robert A
Ziska Suzanne
LandOfFree
Controlled-release galantamine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled-release galantamine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled-release galantamine formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638829